However, the current literature regarding the impact of estrogens in prostate cancer cell proliferation has been criticized, since the most common human prostate cancer in vitro model (LNCaP cells) have a mutated androgen receptor which is activated by estradiol and has low ER expression overall (42). This evidence concerns the gene ESR1 and Familial prostate cancer.